Over the past three decades, Brian Cairl has honed complex corporate investigation skills in cases covering corruption, municipal fraud, intellectual property infringement, product diversion, counterfeiting, and employee misconduct. As senior managing director and director of Investigations and Risk Advisory at K2 Integrity, Brian works with clients to mitigate a wide range of fraud and corruption risks and to respond to compliance breaches and integrity incidents; he also provides extensive dispute advisory support. Directing a multidisciplinary team of researchers, cyber experts, and forensic accountants, Brian conducts sensitive and complex business intelligence assignments across multiple jurisdictions for corporations in the medical, pharmaceutical, transportation, real estate, construction, and electronics industries.

Before joining K2 Integrity, Brian was an associate managing director at Kroll Advisory Solutions. He began his tenure by monitoring and investigating organized crime within Long Island’s private carting industry. His responsibilities also included investigating labor unions as well as construction projects and local municipalities throughout the tri-state area.

Prior to his time at Kroll, Brian spent 14 years as a Senior Special Investigator and Firearms Instructor for the New York State Attorney General’s Medicaid Fraud Control Unit. While there, he conducted fraud investigations involving the New York State Medicaid system and the federal Medicare system.

Brian also investigated nursing home elder abuse, which ultimately led him to help develop a training curriculum to educate staff members on adult care laws and the legal implications of abusive/negligent care.

Brian graduated from John Jay College of Criminal Justice with a B.S. in criminal justice.

Education and Certifications

  • John Jay College of Criminal Justice, B.S.

Representative Matters

  • Intellectual Property Investigations: Called in to investigate the diversion and counterfeiting of its products by a major pharmaceutical company, Brian led a team of analysts and investigators who identified a company suspected to be involved in the counterfeiting and secured samples of the product in question. Based on information obtained as a result of these evidentiary purchases, it was determined that the product in question was, in fact, counterfeit. This finding assisted in the issuance of a seizure order by a federal judge that was executed at the distributor’s offices and warehouse. During this seizure, counterfeit product was recovered as well as business records indicating the source of the counterfeit products. That finding, and subsequent findings obtained through additional seizures in Canada and Trinidad, resulted in the pharmaceutical company derailing this source of counterfeit product as well as obtaining information that proved helpful in the investigation of future diversion and counterfeiting issues.
  • Executive Impersonation: Brian is often called on to investigate instances of individuals impersonating corporate executives. Recently a client advised that one of its executives, who is associated with a well-known record label, had his name and the logo of the record company used by a person not affiliated with the record company. Further investigation revealed that the impostor was sponsoring contests where would-be recording artists would pay to perform in order to win the grand prize of a face-to-face meeting with an executive from the record company—when in reality neither the record company nor its executive had any knowledge of this arrangement. Utilizing database and social media research capabilities, the impostor was identified and later confronted with the impersonation. The result was the impostor admitting, in writing, that the record company and its executive were in no way involved in the events he was sponsoring and indicating that he would cease and desist from any future mention of the record company or its executives.